°üÀýÅë ÁÖ»ç ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç°º°, °üÀý À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)
Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product ; By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
»óǰÄÚµå : 1421807
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 116 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,149,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,596,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è °üÀýÅë ÁÖ»ç ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 123¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

°üÀýÅëÁõ ÁÖ»çÀÇ ÀûÀÀÁõ È®´ë´Â Å« ±âȸ°¡ ÀÖ½À´Ï´Ù. ÇöÀç °üÀýÅë ÁÖ»ç´Â °ñ°üÀý¿° ¹× °ü·Ã Áúȯ¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¿¬±¸ °³¹ß ³ë·ÂÀ» ÅëÇØ °Ç¿°, Ȱ¾×³¶¿° ¹× ±âŸ ±Ù°ñ°Ý°è Áúȯ°ú °°Àº ´õ ³ÐÀº ¹üÀ§ÀÇ °üÀý ÁúȯÀ» Ä¿¹öÇÒ ¼ö ÀÖ´Â »õ·Î¿î ÀûÀÀÁõÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù.

´ÙÁß Ç÷¼ÒÆÇ Ç÷Àå(PRP), Áٱ⼼Æ÷ Ä¡·á, È÷¾Ë·ç·Ð»ê À¯µµÃ¼ µî »ý¹°ÇÐÀû °üÀýÅë ÁÖ»çÀÇ °³¹ß ¹× »ç¿ëÀº ÁÖ¸ñÇÒ ¸¸ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦ ÁÖ»ç´Â Àç»ý °¡´É¼ºÀÌ ÀÖ¾î Á¶Á÷ ȸº¹°ú Ä¡À¯¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. °üÀýÅë ÁÖ»ç ½ÃÀå¿¡ »ý¹°ÇÐÀû Á¦Á¦¸¦ µµÀÔÇÏ¸é Æ¯È÷ °üÀý Áúȯ¿¡ ´ëÇÑ Àç»ý ¼Ö·ç¼ÇÀ» ¿øÇϴ ȯÀڵ鿡°Ô Áøº¸ÀûÀ̰í ÀüüÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

°³º° ¸ÂÃã ÀÇ·á´Â ´Ù¾çÇÑ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ƯÁ¤ °üÀý »óÅÂ, º´·Â, À¯ÀüÀû ¿äÀο¡ µû¶ó ȯÀÚ °³°³ÀÎÀÇ °üÀýÅë Áֻ縦 ¸ÂÃãÈ­Çϸé Ä¡·á °á°ú¸¦ Å©°Ô Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÇ·áÁøÀº ¾à¹° ¼±ÅÃ, º¹¿ë·®, Ä¡·á °èȹÀ» ¸ÂÃãÈ­ÇÔÀ¸·Î½á °üÀýÅë ÁÖ»çÀÇ È¿°ú¸¦ ÃÖÀûÈ­Çϰí ȯÀÚ¿¡°Ô ¸ÂÃãÈ­µÈ °í±Þ ÅëÁõ °ü¸® ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

Æ÷½ºÆ® Äڷγª ½Ã´ë¿¡´Â ¿ø°Ý ÀÇ·á¿Í °¡»ó ÀÇ·á »ó´ãÀÌ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ȯÀÚµéÀº °üÀýÅë ¹®Á¦¸¦ ¿ø°ÝÀ¸·Î »ó´ãÇÏ´Â °ÍÀ» Á¡Á¡ ´õ ¼±È£Çϰí ÀÖÀ¸¸ç, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â °üÀýÅë Æò°¡, Áø´Ü ¹× ÁÖ»ç ó¹æ¿¡ ¿ø°Ý ÀǷḦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº ÆíÀǼºÀ» Á¦°øÇÏ°í ´ë¸é Áø·áÀÇ Çʿ伺À» ÁÙ¿©ÁÖ¸ç, ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ È¯ÀÚµéÀÇ ¼±È£µµ º¯È­¿Íµµ ÀÏÄ¡ÇÕ´Ï´Ù.

ȯÀÚ °æÇèÀº Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀ̴ ȯÀÚ Áß½ÉÀÇ È¯°æÀ» Á¶¼ºÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½Ä¿¡´Â °­È­µÈ Ä¿¹Â´ÏÄÉÀ̼Ç, ¸ÂÃã Ä¡·á °èȹ, °üÀýÅë Áֻ縦 ¿øÇϴ ȯÀÚ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Áö¿ø µîÀÌ Æ÷ÇԵ˴ϴÙ.

°üÀýÅë ÁÖ»ç ½ÃÀå º¸°í¼­ - ÁÖ¿ä ³»¿ë

È÷¾Ë·ç·Ð»ê ÁÖ»ç´Â ÅëÁõ ¿ÏÈ­ ¹× °üÀý °³¼±À» À§ÇÑ ºñ¼ö¼úÀû ´ë¾È¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °¡Àå Å« ºÎ¹®À¸·Î ºÎ»óÇß½À´Ï´Ù.

³ôÀº ¹«¸­ °ü·Ã Áúȯ À¯º´·ü, Àúħ½ÀÀû Ä¡·á ¼±È£µµ, ȯÀÚµéÀÇ ÀÎ½Ä Áõ°¡·Î ÀÎÇØ ¹«¸­ÀÌ °¡Àå Å« ºÎ¹®À¸·Î ºÎ»ó

ÁÖ·Î ¼ÒºñÀÚ ¼ö¿ä Áõ°¡, ÆíÀǼº, Á¢±Ù¼º, ÀüÀÚ»ó°Å·¡¿ÍÀÇ ÅëÇÕÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.

ºÏ¹Ì´Â Àα¸ °í·ÉÈ­, °ñ°üÀý¿°°ú °°Àº °üÀý °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡, ºñ¼ö¼úÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀå Á¡À¯À²ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ °üÀýÅë ÁÖ»ç ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ °üÀýÅë ÁÖ»ç ½ÃÀå, Á¦Ç°º°

Á¦6Àå ¼¼°èÀÇ °üÀýÅë ÁÖ»ç ½ÃÀå, À¯Åë ä³Îº°

Á¦7Àå ¼¼°èÀÇ °üÀýÅë ÁÖ»ç ½ÃÀå, °üÀý À¯Çüº°

Á¦8Àå ¼¼°èÀÇ °üÀýÅë ÁÖ»ç ½ÃÀå, Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global joint pain injections market size is expected to reach USD 12.36 billion by 2032, according to a new study by Polaris Market Research. The report "Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, Stem Cell Injections, Others); By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

There is a significant opportunity to expand the indications for joint pain injections. Currently, these injections are used for osteoarthritis and related conditions. However, research and development efforts are exploring new indications, potentially covering a broader range of joint conditions, such as tendinitis, bursitis, and other musculoskeletal disorders.

The development and use of biologic joint pain injections, including platelet-rich plasma (PRP), stem cell therapies, and hyaluronic acid derivatives, present a notable growth opportunity. Biologic injections have regenerative potential and can stimulate tissue repair and healing. Incorporating biologics into the joint pain injection market introduces advanced and holistic treatment options, particularly for patients seeking regenerative solutions for their joint conditions.

Personalized medicine is gaining prominence across various healthcare sectors. Tailoring joint pain injections to individual patients based on their specific joint condition, medical history, and genetic factors significantly enhances treatment outcomes. By customizing the choice of medication, dosage, and treatment plan, healthcare providers optimize the effectiveness of joint pain injections and deliver highly tailored pain management solutions to patients.

The adoption of telemedicine and virtual healthcare consultations has become more widespread in the post-COVID era. Patients are increasingly open to discussing joint pain issues remotely, and healthcare providers are leveraging telemedicine to evaluate, diagnose, and prescribe joint pain injections. This integration offers convenience and reduces the need for in-person visits, which aligns with pandemic-induced changes in patient preferences.

The patient experience has gained significance. Healthcare providers are focusing on creating a patient-centered environment that fosters trust and satisfaction. This approach includes enhanced communication, personalized care plans, and comprehensive support for individuals seeking joint pain injections.

Joint Pain Injections Market Report Highlights

Hyaluronic acid injections emerged as the largest segment on account of greater demand for non-surgical alternatives for pain relief and joint improvement

Knee emerged as the largest segment on account of higher incidence of knee-related conditions, preference towards less invasive treatments, and increased patient awareness

Retail pharmacies held the maximum market revenue share in 2022, mainly due to growing consumer demand, convenience, easy access, and e-commerce integration

North America region dominated the market with a majority share in 2022, owing to an aging population, rising prevalence of joint-related conditions like osteoarthritis, and growing demand for non-surgical treatment options

The global key market players include: Anika Therapeutics, Bioventus, Eli Lilly and Company, Ferring Pharmaceuticals, and Pacira BioSciences, Inc., among others

Polaris Market Research has segmented the Joint Pain Injections market report based on product, joint type, distribution channel, and region:

Joint Pain Injections, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Joint Pain Injections, Joint Type Outlook (Revenue - USD Billion, 2019 - 2032)

Joint Pain Injections, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Joint Pain Injections, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Joint Pain Injections Market Insights

5. Global Joint Pain Injections Market, by Product

6. Global Joint Pain Injections Market, by Distribution Channel

7. Global Joint Pain Injections Market, by Joint Type

8. Global Joint Pain Injections Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â